This multicenter , double-blind , placebo-controlled study was performed in patients with mixed dyslipidemia ( fasting triglycerides , 150 mg/dL ; high-density lipoprotein cholesterol , 45 [ men ] or 55 mg/dL [ women ] ; low-density lipoprotein cholesterol , 100 mg/dL once and averaging 105 mg/dL ) and a history of coronary heart disease or risk equivalent .